With the increase of survival rates of pediatric cancer patients, the number of children facing potential cognitive sequelae has grown. Previous adult studies suggest that white matter (WM) microstructural changes may contribute to cognitive impairment. This study aims to investigate WM microstructure in childhood bone and soft tissue sarcoma. Differences in (micro-)structure can be investigated using diffusion MRI (dMRI). The typically used diffusion tensor model (DTI) assumes Gaussian diffusion, and lacks information about fiber populations. In this study, we compare WM structure of childhood bone and soft tissue sarcoma survivors (n 5 34) and matched controls (n 5 34), combining typical and advanced voxel-based models (DTI and NODDI model, respectively), as well as recently developed fixel-based models (for estimations of intra-voxel differences, apparent fiber density [AFD] and fiber cross-section [FC]). Parameters with significant findings were compared between treatments, and correlated with subscales of the WAIS-IV intelligence test, age at diagnosis, age at assessment and time since diagnosis. We encountered extensive regions showing lower fractional anisotropy, overlapping with both significant NODDI parameters and fixel-based parameters. In contrast to these diffuse differences, the fixel-based measure of AFD was reduced in the cingulum and corpus callosum only. Furthermore, AFD of the corpus callosum was significantly predicted by chemotherapy treatment and correlated positively with time since diagnosis, visual puzzles and similarities task scores. This study suggests altered WM structure of childhood bone and soft tissue sarcoma survivors. We conclude global chemotherapy-related changes, with particular vulnerability of centrally located WM bundles.
becomes essential to trace potential neurotoxic mechanisms. For pediatric oncology, it is well-known that cranial irradiation leads to cognitive deficits in brain tumor patients (Chang et al., 2009; McDuff et al., 2013) and leukemia patients (Buizer Buizer, De Sonneville, Van Den Heuvel-Eibrink, & Veerman, 2005; Giralt et al., 1992; Krull et al., 2013; Sleurs et al., 20162016b) . Consequently, treatment for leukemia patients was replaced by CNS-directed chemotherapy.
Still, evidence also exists for cognitive decline due to CNS-directed chemotherapy, even without radiotherapy (Khong et al., 2006; Krull et al., 2013; and Moleskiski, 2000) . Most difficulties were reported for executive functioning (Buizer et al., 2005; Caron et al., 2009; KadanLottick et al., 2010) . In line with these cognitive studies, recent neuroimaging studies have also evidenced white matter (WM; Edelmann et al., 2014; Elalfy et al., 2014; Kesler, Gugel, Huston-Warren, & Watson, 2016; Schuitema et al., 2012; Schuitema et al., 2013) and grey matter changes due to CNS-directed chemotherapy (Koppelmans, Breteler, Boogerd, Seynaeve, & Schagen, 2013; Krull et al., 2016; Tamnes et al., 2015) . In contrast to the large number of reports about late neurocognitive sequelae in leukemia (van der Plas et al., 2015) , only limited research has been conducted on childhood solid non-CNS tumors (Sleurs et al., 2016a) . Recently, a few studies have reported cognitive outcomes of childhood solid non-CNS tumor survivors. Mohrmann and colleagues have shown that one-third of solid non-CNS tumor patients experience cognitive complaints later in life (Mohrmann et al., 2015) . For rhabdomyosarcoma, a recent survivor study also evidenced higher risk for depression and task efficiency problems (Schapiro et al., 2015) . Patients using psychopharmaca for anxiety or depression appeared to be most vulnerable. In addition, a recent study performed by Edelman and colleagues, demonstrated lower reading skills, attention, memory and processing speed in survivors of osteosarcoma (Edelmann et al., 2016) .
Not only the number of behavioral studies remains limited for these patients, neuroimaging studies in childhood non-CNS solid tumor survivors have not been performed yet. Still, adult studies have reported alterations of the WM microstructure in solid tumor patients (including breast and testicular cancer; Ahles et al., 2014; Amidi et al., 2016; Deprez et al., 2011; Deprez, Billiet, Sunaert, & Leemans, 2013; McDonald et al., 2010) . Nowadays, MR diffusion-weighted neuroimaging is used to characterize the WM microstructure, and assess possible changes after treatments. These studies typically implement the diffusion tensor imaging (DTI) model, modeling the diffusion of water molecules in each voxel as a 3D Gaussian distribution (Madden, Bennett, & Song, 2009 ).
In the cancer patient groups previously described, DTI-derived parameters such as fractional anisotropy (FA) or mean diffusivity often showed differences in multiple regions, scattered throughout the brain (Abraham et al., 2008; Koppelmans et al., 2014; Partridge et al., 2010; De Ruiter et al., 2012; Schuitema et al., 2013) . However, the cellular microstructure in biological tissue can lead to hindered, non-Gaussian diffusion, for which the DTI model is inadequate. Hence, advanced models should include information of more specific microstructural compartments of the tissue. One of these compartment models is Neurite Orientation Dispersion and Density Imaging (NODDI; Zhang et al., 2012) . This is a threecompartment model of WM microstructure: intra-axonal space, extraaxonal space, and the cerebrospinal fluid. According to the model, water movement in the intra-axonal space depends on the orientation dispersion of tracts. Anisotropic and isotropic Gaussian distributions of movement are assumed for the extra-axonal space and cerebrovascular fluid, respectively. Using these biophysical assumptions, the NODDI model derives parameters for Neurite Density (NDI), orientation dispersion index (ODI) and isotropic volume fraction (VISO) to characterize WM microstructure.
Still, these parameters are voxel-based, while WM voxels are typically occupied by multiple fiber populations, resulting in crossing fibers (Jeurissen et al., 2013) . In other words, changes measured by voxelbased parameters (i.e., based on the DTI or NODDI model), are not fiber-specific. To overcome this limitation, Raffelt and colleagues have recently developed the so-called "Fixel-based" analysis (Raffelt et al., 2016) . Instead of calculating voxel-based parameters, the concept "fixel" was introduced to refer to individual fiber populations within a voxel, segmented from the fiber orientation distribution (FOD) within a voxel. Hence, fiber-specific WM microstructure can be modeled in each direction, and provide more detailed information about specific fiber bundles. Specifically, fixel-based parameters can model changes at both microstructural level (e.g., apparent fiber density, AFD) and macroscopic level (e.g., fiber cross-section, FC).
In this study, we compare WM microstructure between childhood bone and soft tissue sarcoma survivors and healthy matched controls, by using both fixel-based and voxel-based analyses. In addition, we investigate the link between IQ subscales and diffusion metrics. This way, we aim to investigate the WM microstructure as underlying neural substrate for cognitive functioning in more detail. We hypothesize that if WM development is affected by chemotherapy during childhood, differences are expected in the diffusion-derived parameters. Specifically, if WM differences are different at macroscopic versus microscopic level, the fixel-based analysis (FBA) could demonstrate such distinctions and show fiber-specific changes.
| M ET HO D S

| Participants
We acquired dMRI in 34 survivors of pediatric solid non-CNS tumors and 34 healthy age-and gender-matched controls. The patient group consisted of survivors of bone and soft tissue sarcomas (n 5 treated according to the chemotherapy protocols EURAMOS1 (n 5 13), RMS2005 (n 5 3), NRSTS2005 (n 5 1), Euro-Ewing99 (n 5 7), MMT95 (n 5 5), EORTC2001 (n 5 3), IVAD (n 5 1), which included intravenous chemotherapy only (1 survivor was excluded due to cranial irradiation).
Adult survivors were included at least 2 years after treatment at the Uni- 
| Data acquisition
Images were acquired on a 3T Philips Achieva MRI scanner with a 32-channel phased-array head coil. The echo-planar, multi-shell diffusion imaging scheme consisted of b values 700, 1000, and 2800 s/mm 2 , applied along 25, 40, and 75 uniformly distributed gradient directions respectively, in addition to 10 non-diffusion-weighted images (b 5 0). This multi-shell scheme including a high b value, allows us to apply the advanced diffusion models. For all diffusion series, the following acquisition parameters were constant: TR/TE 5 7800/90 ms, 50 slices, voxel resolution of 2.5 3 2.5 3 2.5 m. The total acquisition time for the diffusion-weighted scans was 25 min.
In addition to the neuroimaging data, the WAIS-IV intelligence test was acquired in all subjects on the same day. The main subscales were investigated as neurocognitive outcome of interest, including Verbal Comprehension Index subscales (i.e., Similarities, Vocabulary, Information), Perceptual Reasoning Index (i.e., Block Design, Matrix Reasoning, Visual Puzzles), Working Memory (i.e., Digit Span and Arithmetic) and Processing Speed (i.e., Symbol Search and Coding). Descriptive statistics of the main scales for this population and included data, see Supporting Information Table S1 ).
| Data processing
To investigate the WM of survivors in detail, both voxel-based and fixel-based analyses are used. For a schematic overview of these analyses, see Figure 1 .
| Voxel-based analyses
DWI preprocessing including motion-and eddy current induced distortion correction was performed using ExploreDTI (Leemans, Jeurissen, Sijbers, & Jones, 2009) , DWI bias field correction (Tustison et al., 2010) and global intensity normalization (Raffelt et al., 2012) was performed using MRtrix3 (Tournier, Calamante, & Connelly, 2012) . The corrected DWI images were then fitted with the (a) diffusion tensor model (DTI) to generate FA maps using MRtrix3 and (b) the NODDI model using the NODDI Matlab toolbox (Zhang et al., 2012) , resulting in three additional parameter maps: NDI, VISO, ODI. The corrected DWI images were then used to compute FODs, using robust constrained spherical deconvolution with a group average response function (based on the highest shell data [b 5 2,800]). To be able to make interindividual comparisons at group-level, individual maps should be registered to the same space.
Hence, individual FODs were registered diffeomorphically to a population-based FOD-atlas (Raffelt et al., 2011) , which was created based on 20 individual FOD-maps (10 patients and 10 controls; mean age of subgroup: 20.83 years old [range 16.14-25.69]; see Figure 2 ). This selection was required to limit the duration of the atlas calculation.
Transformation fields of these registrations were applied to individual FA-, NDI-, ODI-, and VISO-maps.
| Fixel-based analyses
Fixel-based parameters were calculated as described by Raffelt and colleagues, using MRtrix3 (Raffelt et al., 2015) . FODs were used to segment (Raffelt et al., 2012) . This measure is correlated with the relative intra-axonal volume of fibers along the main direction of that lobe. The second fixel-based parameter, fiber bundle cross-section (FC), is a macroscopic measure representing changes in the number of voxels that a specific tract bundle occupies. FC is computed based on the non-linear FOD registration step, as the cross-sectional change in the plane perpendicular to the fixel orientation. Smoothing and cluster enhancement was applied in a fixel-based manner, instead of voxel-based (Raffelt et al., 2015) .
| Statistics
WM microstructure was compared between the solid non-CNS tumor survivor group and healthy controls by using multiple t tests (p < .05).
Threshold-free cluster enhancement was applied for voxel-based parameters (i.e., FA-, ODI-, NDI-, and VISO-maps; Smith, & Nichols, 2009 ) and connectivity-based fixel enhancement for measures of FD and FC in all WM fixels (i.e., AFD and FC). 12 t tests tests were performed (i.e., FA, ODI, NDI, VISO, AFD, and FC [6] 3 patients > controls and vice versa [2] ). p values were calculated for each fixel using nonparametric permutation testing (5,000 permutations), and family-wise error corrected for multiple comparisons. Finally, stringent bonferronicorrection (p < .05/12) was applied to investigate most significant differences more in detail. In Figure 3 , we depict the expected value changes in case of specific WM changes. 
| Fixel-based analyses
Given that the typical single-tensor (i.e., DTI) measures can be affected by the amount of fiber populations in the voxels, FBA was performed.
Similar to the widespread differences of FA and VISO, FC is also lower throughout the brain in the patient group. As shown in Figure 5 , this measure overlaps with lower FA, higher VISO and higher NDI values.
By contrast, AFD is lower in specific tracts, including the corpus callosum, the cingulum and a small part of the corticopontine tract. In conclusion, the scattered differences of FA and VISO overlap with both fixel parameters FC and fiber density, but differences in AFD seem FIG URE 2 Population-based atlas of FODs. To be able to make interindividual comparisons, individual FODs were calculated, using robust constrained spherical deconvolution (Tournier, Calamante, & Connelly, 2013) . Individual FOD maps were diffeomorphically registered to the population-based FOD-atlas [Color figure can be viewed at wileyonlinelibrary.com] limited to single tracts (see Figure 6 ). AFD in the corpus appeared most significantly different, which remained after Bonferroni corrections.
Finally, the fixel-based and voxel-based parameters indicated additional significant regions, which were not detected by the other modality (i.e., voxel-based and fixel-based, respectively).
3.3 | WM structure, intellectual outcome, therapy dose, and timing
The region showing significant differences (p < .05) in the most diffusion parameters, was the posterior part of the corpus callosum body (Figures 5 and 6) . AFD was most significant in this region (most significant fixels in this region showed p < .01). Hence, this parameter was calculated for each individual within this region. The mean AFD was specifically calculated within the central part of the corpus callosum (coronal view), which showed significantly lower AFD. Probabilistic fiber tracking in this region was performed, based on the FOD template, to use as mask (see Figure 6 ). This specific AFD measure was compared between chemotherapy protocols (using a univariate ANOVA) and used to correlate with timing variables: age at diagnosis, time since treatment and age at assessment, as well as with the subscales of the WAIS-IV. First, AFD was significantly predicted by the treatment protocol (F(7,1) 5 3.080, p 5 .008). More specifically, AFD appeared lowest for patients treated according to the EURAMOS1 and RMS05 treatment (see Figure 7) . However, for specific chemotherapy doses within these protocols, no clear associations were encountered (see Supporting Information Figure S1 ). Mean AFD did not correlate significantly with age at diagnosis, age at assessment (r 5 2.068, p 5 .708; r 5 .030, p 5 .809, respectively; see Table S2 ). In contrast, time since diagnosis and task scores on visual puzzles and similarities were positively correlated with mean AFD (r 5 .366, p 5 .036; r 5 .262, p 5 .032; r 5 .288 p 5 .018, respectively; see Figure 7 ).
| D ISCUSSION
This study showed the first findings of potential WM alterations in childhood solid non-CNS tumor survivors, that is bone and soft tissue sarcomas, on average 10 years after chemotherapy-treatment, when compared to healthy controls. This was the first childhood cancer survivor study investigating long-term microstructural changes using advanced imaging methods. By expanding the standard voxel-based analyses of FA (i.e., based on the DTI model) to NODDI and FBA, distinctions could be made between different origins of WM changes.
This study showed widespread differences between patients and controls, with lower values of FA (DTI), increased VISO (NODDI) and reduced FC in patients, while lower AFD appeared only in specific WM tracts in patients (FBA). However, after stringent Bonferroni corrections, only widespread VISO and AFD in the corpus callosum remained significant. The fiber density measure also appeared to be related to time since diagnosis and verbal and visual subtask scores. Using these advanced methods, we demonstrated microstructural changes even in cases who did not show WM lesions. (Schuitema et al., 2012) . Healthy aging studies typically report decreases in FA values throughout lifespan after the age of 30 years (Kochunov et al., 2012) . The differences in FA did not remain after Bonferroni correction. However, this correction could be a rather stringent method in this case, given that the NODDI analyses showed an overlap between lower FA and higher VISO. This latter measure clearly remained significant after corrections. A recent study of Billiet and colleagues yielded similar results related to aging throughout lifespan, with increases in VISO and NDI and decrease in FA (Billiet et al., 2015) . Similar to our study, they did not encounter differences in ODI. Since ODI did not differ between our survivor group and controls, we assume that the diffuse pattern of higher VISO and lower FA is not due to increased neurite dispersion but due to the relative amount of fluid in the extra-cellular space. Such elevated levels of extra-cellular fluid could suggest widespread changes due to WM atrophy or cerebral edema. Periventricular changes related to fluid retention, could also explain altered NDI of the corticospinal tract. Neurotoxic mechanisms including ischemic hypoxia, encephalopathy, cardiac arrest, inflammatory processes, etc. (Abbott, 2004) could result in elevated interstitial fluid. Although the VISO parameter suggests increased interstitial fluid, voxel-based parameters are affected by multiple tissue changes, including axonal loss, axonal density, axon diameter, myelination, gliosis etc., which cannot be easily disentangled (Concha, 2014) . Furthermore, in crossing fiber regions, the degeneration of tracts can even lead to higher anisotropy, which makes the interpretation of voxel-based measures difficult. Tensor-derived metrics, such as FA are also more affected by periventricular partial volume effects given the remaining csf signal in lower b values. Given that only the higher shell b 5 2800 data were used for CSD-derived metrics, these effects should be smaller. Therefore, we assume the fixel-based measure to be less dependent on the overall amount of WM, and partial volume fractions. By using fixelbased analyses, we could provide essential additional information in this study.
| Distinction between global and local differences in fixel-based measures
In accordance with the diffuse differences in VISO and FA, the fixelbased measure of the fiber-cross-section also appeared to be widely affected. The lower FC values support the hypothesis of decreased axon bundle thickness, which could be due to atrophy or interstitial fluid retention. In contrast, with regard to the microstructural measure of AFD, differences were encountered only in the single tracts of the corpus callosum, the cingulum and the corticopontine tract. Since AFD is different in specific fiber populations, one could hypothesize that these centrally-located tracts are specifically vulnerable for microstructural changes in pediatric chemotherapy. The vulnerability of central tracts could be explained by their dense axonal packing and their high vascular supply (Garg et al., 2015) . More specifically, after Bonferroni corrections, AFD appeared only significant in the corpus callosum. As described by Garg and colleagues (2015) , the corpus callosum would be especially vulnerable to demyelination and inflammatory processes, which could reduce the intra-axonal compartment volume fraction in these regions. This region was already suggested to be vulnerable to toxicity earlier due to chemotherapy , but also due to alcohol abuse as well (Kapogiannis et al., 2012; Smith et al., 2017) .
Such specific sensitivity of the corpus callosum could explain the observed decrease in AFD in this region. Although metrics derived from higher shell data (b 5 2800) are less affected by CSF volume effects, one should note that highly variable partial volumes in small structures might affect significance levels. By contrast, larger structures FIG URE 8 Scatter plots depicting the relationship between timing variables and AFD in the corpus callosum. Timing variables including time since diagnosis, age at diagnosis and age at assessment are depicted against AFD that was measured in the significant region within the corpus callosum [Color figure can be viewed at wileyonlinelibrary.com] such as the corpus callosum would be less affected by such volume effects (Vos, Jones, Viergever, & Leemans, 2011). 4.3 | Microstructural differences, intelligence scores, chemotherapy, and timing Finally, the specific measure of fiber density in the corpus callosum was associated with chemotherapy protocol, time since diagnosis and intelligence subtask scores. Specifically, survivors treated according to the EURAMOS1 and RMS05 protocol, showed lower apparent fiber densitiy in the corpus callosum. Similarly, StoutenKemperman and colleagues (Stouten-Kemperman et al., 2015) showed that patients exposed to higher doses of chemotherapy are probably more vulnerable to neurotoxicity. However, the protocols included in our study prescribe different chemotherapy agents. The first protocol mainly includes methotrexate, cisplatin and doxorubicin Whelan et al., 2015) , whereas the second protocol mainly prescribes ifosfamide, vincristine and actinomycin (Ferrari et al., 2017) . As our survivor group was limited to 33 subjects, this study was not able to investigate the effects of specific agents included in these protocols. Multiple chemotherapy protocols were included in this study, which resulted in heterogeneity in the patient group. Still, all treatments included at least one high-dose chemotherapy agent (methotrexate and/or ifosfamide). Furthermore, as higher chemotherapy doses are administered in case of larger, more aggressive tumors, or metastases, these factors could also indirectly be related to potential neurotoxicity. Nevertheless, additional figures did not show clear trends in AFD related to cumulative chemotherapy doses (see Supporting Information Figure S1 ). This suggests that neurotoxicity probably arises in case of certain combinations of agents, and depending on an individual's vulnerability, rather than due to only the dose of one specific agent. In addition, the significant group difference in AFD was measured between survivors and control participants, at group level. During recruitment of patients, 52% of the existing database of patients (inclusion criterium: treated according to the predefined chemotherapy protocols, >2 years out of treatment) participated. Given that times since diagnosis were similar between the participating and non-participating patients, we assume that this dataset was representative for all patients. Nonetheless, we note that the ratio of osteosarcoma patients was higher in participating than in non-participating patients. Given that these patients often receive high-dose chemotherapy, we cannot exclude this higher ratio to have affected our results. Furthermore, although this study showed group-based effects for bone and soft tissue sarcoma patients, larger samples are necessary to investigate vulnerability of specific subgroups and differentiate between specific chemotherapy agents. At this stage, it remains uncertain which individual factors play a role in therapy-induced toxicity affecting the WM. Besides neurotoxicity, also differences in SES could have an important impact on brain development during childhood. In this regard, one should note that SES scores were significantly lower in patients. This might highly affect the group comparison results.
Although it is complicated to investigate the independent effect of this measure on imaging values or any cognitive value, since these are highly correlated, additional analyses showed that significant group differences in diffusion metrics still remain after statistical correction for SES. With regard to cognitive measures, visual puzzles and similarities subtask scores were positively correlated with corpus callosal fiber density. Both these subtasks require matching skills and logical reasoning. Puzzles require visuospatial matching and manual coordination. Previous studies have clearly indicated the important role of the corpus callosum in bimanual coordination (Gooijers & Swinnen, 2014) . By contrast, the ability to find similarities between words depends more on conceptual matching (cognitive semantics). As our measure of AFD was derived from the posterior part of the corpus callosum, we mainly investigated the link between parietal and occipital lobe connectivity and intellectual outcome. This region could play an important role in conceptual and visual matching skills. However, we cannot exclude that the global macrostructural changes (as measured with VISO, FA, and FC) can affect multiple other cognitive domains as well.
Finally, we encountered a significant correlation between time since diagnosis and AFD of the corpus callosum, suggestive of a recovery pattern after treatment. In this respect, Armstrong and colleagues recently summarized the processes of axon regeneration and remyelination in case of brain injury (Armstrong et al., 2016a) . They demonstrate the natural tendency of the WM to remyelate after inflammation or vascular damage (Armstrong et al., 2016b) . Since chemotherapy could induce such neurotoxic processes (Ahles & Saykin, 2007; Sleurs et al., 2016a) , leading to microstructural changes, recovery processes could arise in childhood cancer patients as well. Furthermore, recently a similar potential recovery was detected in FA values 3 years after treatment in breast cancer patients (Billiet et al., 2015) . This would explain a positive trend in AFD throughout time. Although a positive trend with age at diagnosis was expected as well, this correlation was not significant. Still, other pediatric oncology (i.e., brain tumor and leukemia) studies also evidenced higher neurotoxic vulnerability of the younger patients at diagnosis (Buizer et al., 2005; Caron et al., 2009; Sleurs et al., 2016b; von der Weid et al., 2003) . Patients in our study were on average 13 years old at diagnosis. Although the age at diagnosis ranged between 5 and 18 years, the majority of the patients were older than 10 years at diagnosis (91%). It can be assumed that underrepresentation of this younger patient group would explain the lack of correlation between age at diagnosis and AFD. If future studies would show similar lack of correlation between age at diagnosis and diffusion parameters in younger patients at diagnosis as well, recovery processes could provide a possible explanation.
| Future directions
By using multiple analysis methods, we aimed to distinguish between several potential tissue changes. First, based on voxel-based analyses, we showed elevated isotropic fractions and lower FA, presumably due to interstitial edema. Second, based on the fixel-based analyses, we showed diffuse macroscopic WM morphological changes (as measured by FC), while microscopic changes (as measured AFD) were limited to SLEURS ET AL. | 9 densely packed WM tracts. In summary, these findings suggest that densely packed WM tracts are mainly vulnerable for microscopic changes, while macrocopic changes are diffuse. Both types of WM changes could lead to lowered ability to transfer information efficiently.
In this respect, lower FA values were related to lower processing speed (Abraham et al., 2008) and attentional functioning (Billiet et al., 2015; Deprez et al., 2011) in breast cancer patients. To investigate which type of WM change leads to specific cognitive difficulties, and processing speed in particular, future studies will be necessary including behavioral measurements. Furthermore, this is the first pilot study showing potential long-term WM microstructural changes in children treated with chemotherapy, using advanced diffusion imaging. Hence, this patient group covered a variety of subgroups of patients (i.e., bone as well as soft tissue sarcoma), treated according to different chemotherapy protocols. In this study, we did not report a relationship between chemotherapy dose and diffusion metrics. Since exploratory analyses did not show differences in AFD of the corpus callosum according to the cumulative doses of individual chemotherapy agents (i.e., methotrexate, cisplatin, carboplatin, doxorubicin, epirubicin, or ifosfamide), statistical analyses were not included in this study to investigate this in detail. Additional diffusion-weighted MRI studies will be necessary to draw firm conclusions about potential predictors for neurotoxic vulnerability. Although this prospective study suggests potential WM changes due to treatment, the underlying physiological processes can not be identified using dMRI alone. Not only specific chemotherapeutic agents could be more toxic, also individual patient characteristics such as therapy metabolism, cardiotoxicity, and genetic predisposition should be further investigated. Finally, we suggest to implement longitudinal studies to investigate potential recovery processes more in detail, since this study only included a cross-subject correlation between time since diagnosis and AFD.
| C ONC LUSI ON
In summary, our study provides the first evidence of changes in the WM structure of childhood survivors of bone and soft tissue sarcoma.
We showed widespread differences in diffusion parameters, suggesting macroscopic changes. Furthermore, microscopic differences in centrally-located tracts could suggest specific vulnerability to vascular or inflammatory mechanisms after disease or treatment, associated with chemotherapy protocol, visual and verbal matching task scores, and time since diagnosis. Advanced diffusion models, such as fixelbased analyses bring additional insights in the mechanisms of diseaseor therapy-induced neurotoxicity and enabled us to differentiate between WM toxicity at the macroscopic versus microscopic level. Still, histological animal and post-mortem studies are necessary to complement these findings.
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